GLSI Since 2020 Annualized Return and Average Annual Return

GLSI Average Annual Return Chart Since 2020
Growth of $10,000.00
Without Dividends Reinvested Into GLSI

Also see:
• GLSI stock yearly return 2021
• GLSI stock yearly return 2022
• GLSI stock yearly return 2023
• GLSI stock yearly return 2024
• GLSI stock yearly return 2025
• GLSI YTD return
Average Annual Return Benchmarks
Compare GLSI average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
GLSI Share Performance
GLSI Average Annual Return Table Since 2020
Start date: 09/28/2020
End date: 07/16/2026
Start price/share: $4.91
End price/share: $19.01
Dividends collected/share: $0.00
Total return: 287.17%
GLSI Average Annual Return: 26.29%
Starting investment: $10,000.00
Ending investment: $38,720.41
Years: 5.80


GLSI average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Greenwich LifeSciences Inc
Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the development of GP2, immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the human epidermal growth factor receptor 2 (HER2)/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers. GP2 is delivered in combination with granulocyte-macrophage colony-stimulating factor to induce GP2 peptide-specific immunity. GP2 treatment is administered via an intradermal injection by mixing GP2 peptide and GM-CSF at the time of administration. The GLSI average annual return since 2020 is shown above.

The Average Annual Return on the GLSI average annual return since 2020 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether GLSI average annual return since 2020 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the GLSI average annual return calculation with any dividends reinvested as applicable (on ex-dates).
GLSI Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree GLSI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Greenwich LifeSciences (GLSI) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

GLUE Average Annual Return
GLXY Average Annual Return
GMED Average Annual Return
GNLX Average Annual Return
GNMX Average Annual Return
GNPX Average Annual Return
GOSS Average Annual Return
GOVX Average Annual Return
GRCE Average Annual Return
GRDN Average Annual Return
More Healthcare companies »
 

GLSI Average Annual Return Since 2020 | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.